Literature DB >> 11850111

Mitochondrial involvement in amyotrophic lateral sclerosis.

Fiona M Menzies1, Paul G Ince, Pamela J Shaw.   

Abstract

The causes of motor neuron death in amyotrophic lateral sclerosis (ALS) are so far unknown. The involvement of mitochondria in the disease was initially suggested by ultrastructural studies. More recently these observations have been supported by studies of mitochondrial function in ALS. Alterations in the activity of complexes which make up the mitochondrial electron transport chain have been recorded as well as mutations in the mitochondrial genome. The calcium buffering function of the mitochondria may also be affected in the disease. This review will discuss how mitochondrial dysfunction could be of relevance in ALS and the evidence that an alteration of mitochondrial function is a feature of the disease. The way in which the involvement of mitochondria fits with other aetiological hypotheses for ALS will also be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11850111     DOI: 10.1016/s0197-0186(01)00125-5

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  49 in total

Review 1.  Neuronal degeneration and mitochondrial dysfunction.

Authors:  Eric A Schon; Giovanni Manfredi
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Packaging of single DNA molecules by the yeast mitochondrial protein Abf2p.

Authors:  Laurence R Brewer; Raymond Friddle; Aleksandr Noy; Enoch Baldwin; Shelley S Martin; Michele Corzett; Rod Balhorn; Ronald J Baskin
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

Review 3.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

4.  A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.

Authors:  Zachary Macchi; Yunxia Wang; Dan Moore; Jonathan Katz; David Saperstein; David Walk; Ericka Simpson; Angela Genge; Tulio Bertorini; J Americo Fernandes; Andrea Swenson; Lauren Elman; Mazen Dimachkie; Laura Herbelin; Joann Miller; Jianghua Lu; Heather Wilkins; Russell H Swerdlow; Jeffrey Statland; Richard Barohn
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-04-02       Impact factor: 4.092

Review 5.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

6.  Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Silvia Ravera; Tiziana Bonifacino; Martina Bartolucci; Marco Milanese; Elena Gallia; Francesca Provenzano; Katia Cortese; Isabella Panfoli; Giambattista Bonanno
Journal:  Mol Neurobiol       Date:  2018-04-14       Impact factor: 5.590

7.  Body mass index delineates ALS from FTD: implications for metabolic health.

Authors:  R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

8.  Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis.

Authors:  B Tomik; J Chwiej; M Szczerbowska-Boruchowska; M Lankosz; S Wójcik; D Adamek; G Falkenberg; S Bohic; A Simionovici; Z Stegowski; A Szczudlik
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

9.  Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons.

Authors:  Shyam D Rao; Hong Z Yin; John H Weiss
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

10.  Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.

Authors:  Manoj Kumar Jaiswal; Wolf-Dieter Zech; Miriam Goos; Christine Leutbecher; Alberto Ferri; Annette Zippelius; Maria Teresa Carrì; Roland Nau; Bernhard U Keller
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.